{"id":"https://openalex.org/W2789217841","doi":"https://doi.org/10.1007/s10637-018-0562-4","title":"Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer","display_name":"Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer","publication_year":2018,"publication_date":"2018-01-19","ids":{"openalex":"https://openalex.org/W2789217841","doi":"https://doi.org/10.1007/s10637-018-0562-4","mag":"2789217841","pmid":"https://pubmed.ncbi.nlm.nih.gov/29349598","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6153514"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-018-0562-4","doi":"https://doi.org/10.1007/s10637-018-0562-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10637-018-0562-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10637-018-0562-4.pdf","source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s10637-018-0562-4.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089392438","display_name":"Andreas Schneewei\u00df","orcid":"https://orcid.org/0000-0002-2429-4512","observed_orcids":["https://orcid.org/0000-0002-2429-4512"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]},{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Schneeweiss","raw_affiliation_strings":["National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075065188","display_name":"Tjoung\u2010Won Park\u2010Simon","orcid":"https://orcid.org/0000-0002-2863-3040","observed_orcids":["https://orcid.org/0000-0002-2863-3040"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tjoung-Won Park-Simon","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Division of Gynecological Oncology and Clinical Research Center, Hannover Medical School, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Division of Gynecological Oncology and Clinical Research Center, Hannover Medical School, Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029048001","display_name":"Joan Albanell","orcid":"https://orcid.org/0000-0003-1239-4580","observed_orcids":["https://orcid.org/0000-0003-1239-4580"]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Joan Albanell","raw_affiliation_strings":["Department of Medical Oncology, Hospital del Mar, CIBERONC, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital del Mar, CIBERONC, Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077199450","display_name":"Ulrik Lassen","orcid":"https://orcid.org/0000-0002-3865-4574","observed_orcids":["https://orcid.org/0000-0002-3865-4574"]},"institutions":[{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Ulrik Lassen","raw_affiliation_strings":["Rigshospitalet, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigshospitalet, Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Cort\u00e9s","raw_affiliation_strings":["Ramon y Cajal University Hospital, Madrid, Spain","Vall d'Hebron Institute of Oncology, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ramon y Cajal University Hospital, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]},{"raw_affiliation_string":"Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056565799","display_name":"Veronique C Dieras","orcid":"https://orcid.org/0000-0001-8094-4738","observed_orcids":["https://orcid.org/0000-0001-8094-4738","https://orcid.org/0000-0002-8798-6540"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Veronique Dieras","raw_affiliation_strings":["Department of Medical Oncology, Institute Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institute Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038403579","display_name":"Marcus May","orcid":"https://orcid.org/0000-0002-7513-4244","observed_orcids":["https://orcid.org/0000-0002-7513-4244"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marcus May","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Division of Gynecological Oncology and Clinical Research Center, Hannover Medical School, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Division of Gynecological Oncology and Clinical Research Center, Hannover Medical School, Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042081568","display_name":"Christoph Schindler","orcid":"https://orcid.org/0000-0002-6779-0057","observed_orcids":["https://orcid.org/0000-0002-6779-0057"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph Schindler","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Division of Gynecological Oncology and Clinical Research Center, Hannover Medical School, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Division of Gynecological Oncology and Clinical Research Center, Hannover Medical School, Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011232197","display_name":"Frederik Marm\u00e9","orcid":"https://orcid.org/0000-0002-6591-3367","observed_orcids":["https://orcid.org/0000-0002-6591-3367"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]},{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Frederik Marm\u00e9","raw_affiliation_strings":["National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015289835","display_name":"Juan Miguel Cejalvo","orcid":"https://orcid.org/0000-0002-8755-8626","observed_orcids":["https://orcid.org/0000-0002-8755-8626"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210158373","display_name":"INCLIVA Health Research Institute","ror":"https://ror.org/059wbyv33","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158373"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Miguel Cejalvo","raw_affiliation_strings":["Department of Medical Oncology, Biomedical Health Research Institute INCLIVA, University of Valencia, Valencia and CIBERONC, Institute of Health Carlos III, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Biomedical Health Research Institute INCLIVA, University of Valencia, Valencia and CIBERONC, Institute of Health Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I16097986","https://openalex.org/I2801357902","https://openalex.org/I4210158373","https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037165485","display_name":"Maria Martinez\u2010Garc\u00eda","orcid":"https://orcid.org/0000-0001-5891-3935","observed_orcids":["https://orcid.org/0000-0001-5891-3935"]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Martinez-Garcia","raw_affiliation_strings":["Department of Medical Oncology, Hospital del Mar, CIBERONC, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital del Mar, CIBERONC, Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113261211","display_name":"Iria Gonz\u00e1lez","orcid":"https://orcid.org/0009-0008-8470-086X","observed_orcids":["https://orcid.org/0009-0008-8470-086X"]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Iria Gonzalez","raw_affiliation_strings":["Department of Medical Oncology, Hospital del Mar, CIBERONC, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital del Mar, CIBERONC, Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080626646","display_name":"Jose Antonio Lopez-Martin","orcid":"https://orcid.org/0000-0001-7530-3207","observed_orcids":["https://orcid.org/0000-0001-7530-3207"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose Lopez-Martin","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035412618","display_name":"Anja Welt","orcid":"https://orcid.org/0000-0002-0948-4385","observed_orcids":["https://orcid.org/0000-0002-0948-4385"]},"institutions":[{"id":"https://openalex.org/I4210119759","display_name":"Essen University Hospital","ror":"https://ror.org/02na8dn90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210119759"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anja Welt","raw_affiliation_strings":["Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany","institution_ids":["https://openalex.org/I4210119759"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049369439","display_name":"Christelle L\u00e9vy","orcid":"https://orcid.org/0000-0003-0572-5222","observed_orcids":["https://orcid.org/0000-0003-0572-5222"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christelle Levy","raw_affiliation_strings":["Departments of Clinical Research Unit and Medical Oncology, Centre Fran\u00e7ois Baclesse, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Research Unit and Medical Oncology, Centre Fran\u00e7ois Baclesse, Caen, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042461515","display_name":"Florence Joly","orcid":"https://orcid.org/0000-0001-7004-9895","observed_orcids":["https://orcid.org/0000-0001-7004-9895","https://orcid.org/0000-0001-6168-4942","https://orcid.org/0000-0001-8018-6359"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Joly","raw_affiliation_strings":["Departments of Clinical Research Unit and Medical Oncology, Centre Fran\u00e7ois Baclesse, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Research Unit and Medical Oncology, Centre Fran\u00e7ois Baclesse, Caen, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091508845","display_name":"Francesca Michielin","orcid":"https://orcid.org/0009-0007-0153-2139","observed_orcids":["https://orcid.org/0009-0007-0153-2139"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Francesca Michielin","raw_affiliation_strings":["Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025990237","display_name":"Wolfgang Jacob","orcid":"https://orcid.org/0000-0002-8171-7542","observed_orcids":["https://orcid.org/0000-0002-8171-7542"]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Wolfgang Jacob","raw_affiliation_strings":["Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany. wolfgang.jacob@roche.com","Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany"],"raw_orcid":"https://orcid.org/0000-0002-8171-7542","affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany. wolfgang.jacob@roche.com","institution_ids":[]},{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032668529","display_name":"C\u00e9line Adessi","orcid":"https://orcid.org/0009-0000-7801-9121","observed_orcids":["https://orcid.org/0009-0000-7801-9121"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"C\u00e9line Adessi","raw_affiliation_strings":["Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060969977","display_name":"Annie Moisan","orcid":"https://orcid.org/0000-0002-4944-4548","observed_orcids":["https://orcid.org/0000-0002-4944-4548"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Annie Moisan","raw_affiliation_strings":["Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082405249","display_name":"Georgina Meneses\u2010Lorente","orcid":"https://orcid.org/0000-0001-8961-0902","observed_orcids":["https://orcid.org/0000-0001-8961-0902"]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Georgina Meneses-Lorente","raw_affiliation_strings":["Pharma Research and Early Development (pRED), Roche Innovation Center Welwyn, Welwyn Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Welwyn, Welwyn Garden City, UK","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tomas Racek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Tomas Racek","raw_affiliation_strings":["Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112008051","display_name":"Ian James","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian James","raw_affiliation_strings":["A4P Consulting Ltd, Sandwich, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A4P Consulting Ltd, Sandwich, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002653345","display_name":"Maurizio Ceppi","orcid":"https://orcid.org/0000-0002-2848-0347","observed_orcids":["https://orcid.org/0000-0002-2848-0347"]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Maurizio Ceppi","raw_affiliation_strings":["Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057758171","display_name":"Max Hasmann","orcid":"https://orcid.org/0000-0002-6188-7843","observed_orcids":["https://orcid.org/0000-0002-6188-7843"]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Max Hasmann","raw_affiliation_strings":["Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024314365","display_name":"Maja Weisser","orcid":"https://orcid.org/0000-0002-0134-1929","observed_orcids":["https://orcid.org/0000-0002-0134-1929"]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Weisser","raw_affiliation_strings":["Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091727687","display_name":"Andr\u00e8s M.R. Cervantes","orcid":"https://orcid.org/0000-0003-3806-3691","observed_orcids":["https://orcid.org/0000-0003-3806-3691","https://orcid.org/0000-0003-4644-3977"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210158373","display_name":"INCLIVA Health Research Institute","ror":"https://ror.org/059wbyv33","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158373"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Andr\u00e9s Cervantes","raw_affiliation_strings":["Department of Medical Oncology, Biomedical Health Research Institute INCLIVA, University of Valencia, Valencia and CIBERONC, Institute of Health Carlos III, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Biomedical Health Research Institute INCLIVA, University of Valencia, Valencia and CIBERONC, Institute of Health Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I16097986","https://openalex.org/I2801357902","https://openalex.org/I4210158373","https://openalex.org/I4210158561"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":19,"corresponding_author_ids":["https://openalex.org/A5025990237"],"corresponding_institution_ids":["https://openalex.org/I4210094361"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":2.6094,"has_fulltext":true,"cited_by_count":78,"citation_normalized_percentile":{"value":0.92725115,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"36","issue":"5","first_page":"848","last_page":"859"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9729999899864197},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.996999979019165},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.6990000009536743},{"id":"https://openalex.org/keywords/her2-low","display_name":"HER2-low","score":0.8360000252723694},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9520000219345093},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.7879999876022339},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8669999837875366},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7929999828338623},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.9815633296966553},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7447258234024048},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7145470976829529},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.702113926410675},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6683443784713745},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6611862182617188},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5140646696090698},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.46940410137176514},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4488013684749603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4051460027694702},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25421270728111267}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007008","descriptor_name":"Hypokalemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020641","descriptor_name":"Polymorphism, Single Nucleotide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020893","descriptor_name":"Receptor, ErbB-3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020893","descriptor_name":"Receptor, ErbB-3","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020893","descriptor_name":"Receptor, ErbB-3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1007/s10637-018-0562-4","doi":"https://doi.org/10.1007/s10637-018-0562-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10637-018-0562-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10637-018-0562-4.pdf","source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5124315","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6153514","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:29349598","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29349598","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:6153514","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6153514/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Invest New Drugs","raw_type":"Text"},{"id":"pmh:oai:pure.atira.dk:openaire/fdcbcbf2-bf5d-4448-bc40-7c52da83ad73","doi":null,"is_oa":true,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/fdcbcbf2-bf5d-4448-bc40-7c52da83ad73","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dnet:ricscm______::35f9cde5f55cd8b4ebbd78ebe815d670","doi":null,"is_oa":true,"landing_page_url":"https://repositoriosaludmadrid.es/handle/20.500.12530/38099","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:repositori.upf.edu:10230/35816","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10230/35816","pdf_url":null,"source":{"id":"https://openalex.org/S4306402615","display_name":"Repositori digital de la UPF (Universitat Pompeu Fabra)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I170486558","host_organization_name":"Universitat Pompeu Fabra","host_organization_lineage":["https://openalex.org/I170486558"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1007/s10637-018-0562-4","doi":"https://doi.org/10.1007/s10637-018-0562-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10637-018-0562-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10637-018-0562-4.pdf","source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2789217841.pdf","grobid_xml":"https://content.openalex.org/works/W2789217841.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1525885958","https://openalex.org/W1828002159","https://openalex.org/W1867789233","https://openalex.org/W1979946545","https://openalex.org/W2019607817","https://openalex.org/W2027515445","https://openalex.org/W2037185844","https://openalex.org/W2044099597","https://openalex.org/W2052766930","https://openalex.org/W2061209959","https://openalex.org/W2096111541","https://openalex.org/W2098775844","https://openalex.org/W2101299592","https://openalex.org/W2101979288","https://openalex.org/W2120661754","https://openalex.org/W2123591186","https://openalex.org/W2126275851","https://openalex.org/W2130900820","https://openalex.org/W2131100244","https://openalex.org/W2137228442","https://openalex.org/W2160574552","https://openalex.org/W2160702055","https://openalex.org/W2166199281","https://openalex.org/W2178676862","https://openalex.org/W2247021348","https://openalex.org/W2315705238","https://openalex.org/W2402692848","https://openalex.org/W2496043878","https://openalex.org/W2542944545","https://openalex.org/W2547100318","https://openalex.org/W2569321792","https://openalex.org/W2590981502","https://openalex.org/W2594607499","https://openalex.org/W2597694248","https://openalex.org/W2612021455","https://openalex.org/W2612760614","https://openalex.org/W2622683766","https://openalex.org/W2766948475","https://openalex.org/W2907449627","https://openalex.org/W4243385540","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2594607499","https://openalex.org/W2798205552","https://openalex.org/W2123446046","https://openalex.org/W2407829433","https://openalex.org/W3000138523","https://openalex.org/W4242166881","https://openalex.org/W4379283868","https://openalex.org/W2767649763","https://openalex.org/W2624170378","https://openalex.org/W2597786088"],"abstract_inverted_index":{"Summary":[0],"Purpose":[1],"To":[2],"investigate":[3],"the":[4,132,171,184,230,235,251],"safety":[5],"and":[6,23,52,58,76,92,144,168,191,195,202,208,219],"clinical":[7,209,244],"activity":[8],"of":[9,128,136,170,227],"comprehensive":[10],"human":[11],"epidermal":[12],"growth":[13],"factor":[14],"receptor":[15,18],"(HER)":[16],"family":[17],"inhibition":[19],"using":[20],"lumretuzumab":[21,65,137],"(anti-HER3)":[22],"pertuzumab":[24,79,143,172,218],"(anti-HER2)":[25],"in":[26,30,68,73,89,98,109,113,140,188],"combination":[27,141],"with":[28,32,50,142,164,216,223,250],"paclitaxel":[29,105,145,220],"patients":[31,45,176],"metastatic":[33],"breast":[34],"cancer":[35],"(MBC).":[36],"Methods":[37],"This":[38],"phase":[39],"Ib":[40],"study":[41],"enrolled":[42],"35":[43],"MBC":[44,182],"(first":[46],"line":[47],"or":[48,205],"higher)":[49],"HER3-positive":[51],"HER2-low":[53],"(immunohistochemistry":[54],"1+":[55],"to":[56,160,232,241],"2+":[57],"in-situ":[59],"hybridization":[60],"negative)":[61],"tumors.":[62],"Patients":[63,112],"received":[64,116],"(1000":[66],"mg":[67,72,81,88,95,148],"Cohort":[69,99,114,129],"1;":[70],"500":[71,147],"Cohorts":[74,90,189],"2":[75,190],"3)":[77,100,163],"plus":[78,104],"(840":[80],"loading":[82],"dose":[83,135],"[LD]":[84],"followed":[85],"by":[86],"420":[87,94],"1":[91,130],"2;":[93],"without":[96],"LD":[97],"every":[101,149],"3":[102,115,123,153,192],"weeks,":[103],"(80":[106],"mg/m2":[107],"weekly":[108],"all":[110,175],"cohorts).":[111],"prophylactic":[117,165],"loperamide":[118,166],"treatment.":[119],"Results":[120],"Diarrhea":[121],"grade":[122],"was":[124,193,211,221],"a":[125,224],"dose-limiting":[126],"toxicity":[127],"defining":[131],"maximum":[133],"tolerated":[134],"when":[138],"given":[139],"at":[146],"three":[150],"weeks.":[151],"Grade":[152],"diarrhea":[154],"decreased":[155],"from":[156],"50%":[157],"(Cohort":[158,162],"2)":[159],"30.8%":[161],"administration":[167],"omission":[169],"LD,":[173],"nonetheless,":[174],"still":[177],"experienced":[178],"diarrhea.":[179,228],"In":[180],"first-line":[181],"patients,":[183],"objective":[185],"response":[186,210],"rate":[187],"55%":[194],"38.5%,":[196],"respectively.":[197],"No":[198],"relationship":[199],"between":[200],"HER2":[201],"HER3":[203],"expression":[204],"somatic":[206],"mutations":[207],"observed.":[212],"Conclusions":[213],"Combination":[214],"treatment":[215],"lumretuzumab,":[217],"associated":[222],"high":[225],"incidence":[226],"Despite":[229],"efforts":[231],"alter":[233],"dosing,":[234],"therapeutic":[236],"window":[237],"remained":[238],"too":[239],"narrow":[240],"warrant":[242],"further":[243],"development.":[245],"Trial":[246],"registration:":[247],"on":[248,256],"ClinicalTrials.gov":[249],"identifier":[252],"NCT01918254":[253],"first":[254],"registered":[255],"3rd":[257],"July":[258],"2013.":[259]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-03-06T00:00:00"}